Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Rink

Showing results (61-70 of 292) with videos related to

Pageof 30
Sort By:
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|October 25, 2023
Rational peri-operative management of antithrombotic therapy in patients undergoing radical cystectomy: A 30-day morbidity analysis based on the updated European Association of Urology guidelines for standardized complication reportingMara Koelker, Marlon Bradtke, Jakob Klemm, et al.
BJU International|September 11, 2012
Cost-effective treatment of low-risk carcinoma not invading bladder muscleDavid A Green, Michael Rink, Eugene K Cha, et al.
European Urology Focus|June 22, 2023
Time-to-complication Patterns After Radical Cystectomy: A Secondary Analysis of a 30-day Morbidity Assessment Using the European Association of Urology Quality Criteria for Standardized ReportingJakob Klemm, Michael Rink, Markus von Deimling, et al.
Journal of Clinical Medicine|July 31, 2019
Negative Self-Perception and Self-Attitude of Sexuality Is a Risk Factor for Patient Dissatisfaction Following Penile Surgery with Small Intestinal Submucosa Grafting for the Treatment of Severe Peyronie's DiseaseArmin Soave, Sebastian Laurich, Roland Dahlem, et al.
International Journal of Cancer|September 27, 2016
A nonrandomized, prospective, clinical study on the impact of circulating tumor cells on outcomes of urothelial carcinoma of the bladder patients treated with radical cystectomy with or without adjuvant chemotherapyArmin Soave, Sabine Riethdorf, Roland Dahlem, et al.
BJU International|April 17, 2012
Role of magnetic resonance imaging in bladder cancer: current status and emerging techniquesDavid A Green, Matthieu Durand, Naveen Gumpeni, et al.
BJU International|August 26, 2010
Detection of circulating tumour cells in peripheral blood of patients with advanced non-metastatic bladder cancerMichael Rink, Felix K H Chun, Sarah Minner, et al.
International Urology and Nephrology|July 26, 2013
Lymph node dissection during radical cystectomy for bladder cancer treatment: considerations on relevance and extentLars Weisbach, Roland Dahlem, Giuseppe Simone, et al.
European Urology|August 3, 2013
Hexyl aminolevulinate-guided fluorescence cystoscopy in the diagnosis and follow-up of patients with non-muscle-invasive bladder cancer: a critical review of the current literatureMichael Rink, Marko Babjuk, James W F Catto, et al.
Urologic Oncology|July 1, 2015
Assessing the clinical benefit of a nomogram to predict specimen-confined disease at radical prostatectomy in patients with high-risk prostate cancer: An external validationJens Hansen, Andreas Becker, Luis A Kluth, et al.
Pageof 30

Showing results (61-70 of 292) with videos related to

Sort By:
Pageof 30
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|October 25, 2023
Rational peri-operative management of antithrombotic therapy in patients undergoing radical cystectomy: A 30-day morbidity analysis based on the updated European Association of Urology guidelines for standardized complication reportingMara Koelker, Marlon Bradtke, Jakob Klemm, et al.
BJU International|September 11, 2012
Cost-effective treatment of low-risk carcinoma not invading bladder muscleDavid A Green, Michael Rink, Eugene K Cha, et al.
European Urology Focus|June 22, 2023
Time-to-complication Patterns After Radical Cystectomy: A Secondary Analysis of a 30-day Morbidity Assessment Using the European Association of Urology Quality Criteria for Standardized ReportingJakob Klemm, Michael Rink, Markus von Deimling, et al.
Journal of Clinical Medicine|July 31, 2019
Negative Self-Perception and Self-Attitude of Sexuality Is a Risk Factor for Patient Dissatisfaction Following Penile Surgery with Small Intestinal Submucosa Grafting for the Treatment of Severe Peyronie's DiseaseArmin Soave, Sebastian Laurich, Roland Dahlem, et al.
International Journal of Cancer|September 27, 2016
A nonrandomized, prospective, clinical study on the impact of circulating tumor cells on outcomes of urothelial carcinoma of the bladder patients treated with radical cystectomy with or without adjuvant chemotherapyArmin Soave, Sabine Riethdorf, Roland Dahlem, et al.
BJU International|April 17, 2012
Role of magnetic resonance imaging in bladder cancer: current status and emerging techniquesDavid A Green, Matthieu Durand, Naveen Gumpeni, et al.
BJU International|August 26, 2010
Detection of circulating tumour cells in peripheral blood of patients with advanced non-metastatic bladder cancerMichael Rink, Felix K H Chun, Sarah Minner, et al.
International Urology and Nephrology|July 26, 2013
Lymph node dissection during radical cystectomy for bladder cancer treatment: considerations on relevance and extentLars Weisbach, Roland Dahlem, Giuseppe Simone, et al.
European Urology|August 3, 2013
Hexyl aminolevulinate-guided fluorescence cystoscopy in the diagnosis and follow-up of patients with non-muscle-invasive bladder cancer: a critical review of the current literatureMichael Rink, Marko Babjuk, James W F Catto, et al.
Urologic Oncology|July 1, 2015
Assessing the clinical benefit of a nomogram to predict specimen-confined disease at radical prostatectomy in patients with high-risk prostate cancer: An external validationJens Hansen, Andreas Becker, Luis A Kluth, et al.
Pageof 30